Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ...

According to Benzinga Pro, Masimo's peer group average for short interest as a percentage of float is 3.82%, which means the ...

Masimo (NASDAQ: MASI) will release third quarter 2024 financial results for the period ended September 28, 2024, after the market closes on Tuesday, November 5, 2024. The conference call to review the ...

Masimo has expanded the board with the addition of former Stryker President Timothy Scannell and Lane Holdings Chair Wendy ...

Buying $1000 In MASI: If an investor had bought $1000 of MASI stock 10 years ago, it would be worth $6,316.76 today based on ...

On Tuesday, Masimo Corp (MASI) stock saw a decline, ending the day at $143.73 which represents a decrease of $-0.32 or -0.22% from the prior close of $144.05. The stock opened at $143.04 and touched a ...

Irvine-based Masimo Corp. announced it has added Timothy Scannell and Wendy Lane to its board of directors, effective ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on Masimo (MASI – Research Report) today and set a price target of $165.00.

Masimo Corporation (MASI) stock gained after Piper Sandler named the company as a top idea citing a potential turnaround in its margins and earnings. Read more here.

Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board Masimo Corporation (Nasdaq: MASI), a leading global ...

An analyst from Piper Sandler maintained a positive stance on Masimo Corp . (NASDAQ:MASI), a medical technology company, reiterating an Overweight rating with a $165.00 price target. The analyst ...